OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock ONCSQ vs. EFTR, AMPE, PXMD, ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, and ACABWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include eFFECTOR Therapeutics (EFTR), Ampio Pharmaceuticals (AMPE), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), and Atlantic Coastal Acquisition Corp. II (ACABW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. eFFECTOR Therapeutics Ampio Pharmaceuticals PaxMedica 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II eFFECTOR Therapeutics (NASDAQ:EFTR) and OncoSec Medical (NASDAQ:ONCSQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Is EFTR or ONCSQ more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A OncoSec Medical N/A N/A N/A Do insiders and institutionals hold more shares of EFTR or ONCSQ? 57.7% of eFFECTOR Therapeutics shares are owned by institutional investors. 4.7% of eFFECTOR Therapeutics shares are owned by insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor EFTR or ONCSQ? eFFECTOR Therapeutics received 23 more outperform votes than OncoSec Medical when rated by MarketBeat users. CompanyUnderperformOutperformeFFECTOR TherapeuticsOutperform Votes2379.31% Underperform Votes620.69% OncoSec MedicalN/AN/A Which has higher earnings and valuation, EFTR or ONCSQ? OncoSec Medical has lower revenue, but higher earnings than eFFECTOR Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR Therapeutics$3.55M0.00-$35.81M-$13.080.00OncoSec MedicalN/AN/A-$34.18MN/AN/A Does the media favor EFTR or ONCSQ? In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral OncoSec Medical Neutral Which has more volatility and risk, EFTR or ONCSQ? eFFECTOR Therapeutics has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, OncoSec Medical has a beta of -19.7, indicating that its share price is 2,070% less volatile than the S&P 500. SummaryeFFECTOR Therapeutics beats OncoSec Medical on 5 of the 6 factors compared between the two stocks. Remove Ads Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$6.75B$5.54B$7.86BDividend YieldN/A2.81%5.35%4.06%P/E RatioN/A7.0923.4418.67Price / SalesN/A199.59367.8787.31Price / CashN/A65.6738.1634.64Price / BookN/A5.966.634.09Net Income-$34.18M$142.11M$3.20B$246.93M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040EFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+3,999,900.0%-100.0%$3,000.00$3.55M0.0010Gap DownAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$2,000.00N/A0.0020Analyst ForecastNews CoveragePXMDPaxMedicaN/A$0.00flatN/A-100.0%$2,000.00N/A0.002ATNFW180 Life SciencesN/A$0.01+6.1%N/A-14.6%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.24-6.8%$30.50+230.1%N/A$0.00N/A0.0018Analyst ForecastNews CoverageAEHAWAesther Healthcare AcquisitionN/A$0.02+0.5%N/A-83.3%$0.00N/A0.002AIMDWAinosN/A$0.11-34.3%N/A+57.1%$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$2.61-10.0%N/A-57.6%$0.00$391.87M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.0015 Remove Ads Related Companies and Tools Related Companies eFFECTOR Therapeutics Alternatives Ampio Pharmaceuticals Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aardvark Therapeutics Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
